Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children

Background: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis. Aim: Aim was to assess the efficacy of desmopressin therapy in the treatm...

Full description

Bibliographic Details
Main Authors: Farida ElBaz, Sally Zahra, Marian Khairy
Format: Article
Language:English
Published: SpringerOpen 2015-07-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110863015000130
_version_ 1818298153598713856
author Farida ElBaz
Sally Zahra
Marian Khairy
author_facet Farida ElBaz
Sally Zahra
Marian Khairy
author_sort Farida ElBaz
collection DOAJ
description Background: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis. Aim: Aim was to assess the efficacy of desmopressin therapy in the treatment of Primary Monosymptomatic Nocturnal Enuresis (PMNE) in Egyptian children. Method: The study assessed 40 children aged 6–15 years suffering from PMNE. They were divided into 2 groups; Group 1 (20 patients) were on desmopressin tablets (0.2 mg) once daily before bedtime for 8 weeks in addition to behavioral modifications. Group 2 received only behavioral modifications. Both groups were followed up for 8 weeks of treatment, and then another 8 weeks to detect relapse. Results: The wetting frequency decreased during treatment by 70% in Group 1 and 65% in Group 2. However, this difference was not statistically significantly different. The complete and partial response rates were 45% and 25% respectively in Group 1 and were 35% and 30% respectively in Group 2. Conclusion: There is a highly significant decrease in wet nights in response to either desmopressin or behavioral therapy. However, the difference is not statistically significant. Also, it was found that relapsers (mainly early relapsers) are significantly more encountered in patients treated by desmopressin.
first_indexed 2024-12-13T04:30:48Z
format Article
id doaj.art-9e1c8dbbc0e246f484c2f5033580f23d
institution Directory Open Access Journal
issn 1110-8630
language English
last_indexed 2024-12-13T04:30:48Z
publishDate 2015-07-01
publisher SpringerOpen
record_format Article
series Egyptian Journal of Medical Human Genetics
spelling doaj.art-9e1c8dbbc0e246f484c2f5033580f23d2022-12-21T23:59:33ZengSpringerOpenEgyptian Journal of Medical Human Genetics1110-86302015-07-0116325726210.1016/j.ejmhg.2015.02.006Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian childrenFarida ElBazSally ZahraMarian KhairyBackground: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis. Aim: Aim was to assess the efficacy of desmopressin therapy in the treatment of Primary Monosymptomatic Nocturnal Enuresis (PMNE) in Egyptian children. Method: The study assessed 40 children aged 6–15 years suffering from PMNE. They were divided into 2 groups; Group 1 (20 patients) were on desmopressin tablets (0.2 mg) once daily before bedtime for 8 weeks in addition to behavioral modifications. Group 2 received only behavioral modifications. Both groups were followed up for 8 weeks of treatment, and then another 8 weeks to detect relapse. Results: The wetting frequency decreased during treatment by 70% in Group 1 and 65% in Group 2. However, this difference was not statistically significantly different. The complete and partial response rates were 45% and 25% respectively in Group 1 and were 35% and 30% respectively in Group 2. Conclusion: There is a highly significant decrease in wet nights in response to either desmopressin or behavioral therapy. However, the difference is not statistically significant. Also, it was found that relapsers (mainly early relapsers) are significantly more encountered in patients treated by desmopressin.http://www.sciencedirect.com/science/article/pii/S1110863015000130Nocturnal enuresisEfficiencyDesmopressinRelapse
spellingShingle Farida ElBaz
Sally Zahra
Marian Khairy
Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
Egyptian Journal of Medical Human Genetics
Nocturnal enuresis
Efficiency
Desmopressin
Relapse
title Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
title_full Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
title_fullStr Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
title_full_unstemmed Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
title_short Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
title_sort assessment of the efficacy of desmopressin in treatment of primary monosymptomatic nocturnal enuresis in egyptian children
topic Nocturnal enuresis
Efficiency
Desmopressin
Relapse
url http://www.sciencedirect.com/science/article/pii/S1110863015000130
work_keys_str_mv AT faridaelbaz assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren
AT sallyzahra assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren
AT mariankhairy assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren